SGK
MEDP icon

Steigerwald Gordon & Koch’s Medpace MEDP Stock Holding History

Steigerwald Gordon & Koch’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Hold
54
– – ﹤0.01% 384
2026
Q1 		$25.9K Hold
54
– – ﹤0.01% 384
2025
Q4 		$30.3K Buy
+54
New +$30.7K ﹤0.01% 388

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Steigerwald Gordon & Koch's MEDP Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Medpace (MEDP) position steady in Q2 2026 at 54 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Steigerwald Gordon & Koch first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.3K in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Steigerwald Gordon & Koch held 54 shares of Medpace worth $28.6K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #384 holding.
  • Steigerwald Gordon & Koch first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Steigerwald Gordon & Koch's Medpace position peaked at $30.3K in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.